Google, drug maker AbbVie invest $500M in health joint venture
SAN FRANCISCO - Google's ambitious health startup is teaming up with biotechnology drugmaker AbbVie in a $500 million joint venture that will try to develop new ways to treat cancer and other diseases such as Alzheimer's.
The alliance announced Wednesday calls for Google Inc. and AbbVie Inc. to each invest $250 million in the project. They will split all expenses and any profits generated by the venture.
Calico, a company created by Google last year, will manage a team of scientists who will work at a research-and-development lab in the San Francisco Bay Area. The precise location and size of the new lab hasn't been determined.
AbbVie, a spin-off from Abbott Laboratories, will oversee the marketing of the drugs.
Calico is run by former Genentech CEO Arthur Levinson.
Please Log In to add a comment.
Best of TechWire Insider
- 10 reasons why you should attend 'Fiber Transforms Triangle' event
- Will your startup 'VAPORIZE'? Marc Andreessen's warning to entrepreneurs, VCs
- Exclusive: IBM affirms RTP's importance with new data center
- Sageworks hopes to incubate new businesses, ideas with I-Lab
- Red Hat reports bug that could devastate 'Internet of Things'
- Novartis dedicates $1B vaccine plant with VIP flu shots as NC exec who recruited the firm will watch
- No Google Fiber news soon for RTP, but digging is furious in Austin
- Is Charlotte really the Silicon Valley of the South?
- Do Apple, Google changes ensure privacy? National Law Journal says no
- New wave of 'undisclosed investors' now powering NC tech startups